In vivo Nanoplatforms for Therapeutics (IVN:Tx)-LOI Due July 18
The specific objective of the IVN:Tx thrust of the In vivo Nanoplatforms (IVN) program is to develop novel, biocompatible nanotherapeutic platforms with sequence, specificity and function that can be programmed “on-the-fly” to treat military-relevant diseases. Successful nanotherapeutic platforms should enable treatment of military-relevant diseases such as infections caused by multi-drug resistant organisms and conditions due to traumatic brain injury.